Volume 133, Issue 5 pp. 504-512

Somatic hypermutation and VH gene usage in hairy cell leukaemia

Evgeny Arons

Evgeny Arons

Clinical Immunotherapy Section, Laboratory of Molecular Biology, Centers for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Search for more papers by this author
Joel Sunshine

Joel Sunshine

Clinical Immunotherapy Section, Laboratory of Molecular Biology, Centers for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Search for more papers by this author
Tara Suntum

Tara Suntum

Clinical Immunotherapy Section, Laboratory of Molecular Biology, Centers for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Search for more papers by this author
Robert J. Kreitman

Robert J. Kreitman

Clinical Immunotherapy Section, Laboratory of Molecular Biology, Centers for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Search for more papers by this author
First published: 27 April 2006
Citations: 35
Robert J. Kreitman, Clinical Immunotherapy Section, Laboratory of Molecular Biology, 9000 Rockville Pike, Building 37, Room 5124b, Bethesda, MD 20892-4255. E-mail: [email protected]

Summary

To examine the usage and mutational status of VH genes in hairy cell leukaemia (HCL), we analysed 24 immunoglobulin heavy chain (IgH) sequences expressed in 23 patients. None had premature stop codons. VH3-23 was the most common gene and a VH6 gene was observed for the first time in HCL. Although the mean mutation frequency was 6·1%, slightly higher than in previous HCL series, four patients had 99·6–100% homology to germline sequences, three of whom had high tumour burdens and poor outcomes. Despite the high mutation frequency, only two of 24 rearrangements had clear statistical evidence of antigen-dependent somatic mutation. Our results increase the database of reported functional HCL rearrangements to 94 in 92 patients. Overall, both gene usage and mutation frequency are very similar to mucosa-associated lymphoid tissue-type marginal zone lymphoma. The data are consistent with HCL originating from post-germinal centre marginal zone B cells, although the heterogeneity observed suggests that HCL may originate differently in some patients, and this could have implications for prognosis and treatment.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.